We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.15%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,185

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCC
4076
DELISTED
Old Market Capital Corp
OMCC
$1K ﹤0.01%
100
-467
-82% -$6.2K
PVLA
4077
Palvella Therapeutics
PVLA
$2.27B
$1K ﹤0.01%
+6
New +$1.32K
SUM
4078
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1K ﹤0.01%
+47
New +$1.12K
AE
4079
DELISTED
Adams Resources & Energy Inc
AE
$1K ﹤0.01%
13
-8
-38% -$407
USAP
4080
DELISTED
Universal Stainless & Alloy
USAP
$1K ﹤0.01%
74
-1,055
-93% -$22.2K
WHLM
4081
DELISTED
Wilhelmina International, Inc
WHLM
$1K ﹤0.01%
170
-636
-79% -$3.45K
TCON
4082
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1K ﹤0.01%
1
-7
-88% -$16.4K
BIOL
4083
DELISTED
Biolase, Inc.
BIOL
0
ERF
4084
DELISTED
Enerplus Corporation
ERF
$1K ﹤0.01%
100
-4,900
-98% -$52.3K
AVGR
4085
DELISTED
Avinger, Inc. Common Stock
AVGR
0
YTEN
4086
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
CHIE
4087
DELISTED
Global X MSCI China Energy ETF
CHIE
$1K ﹤0.01%
+38
New +$562
MARK
4088
DELISTED
Remark Holdings, Inc.
MARK
$1K ﹤0.01%
31
+11
+55% +$450
MDVL
4089
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
0
BETS
4090
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
BNSO
4091
DELISTED
Bonso Electronic International
BNSO
$1K ﹤0.01%
774
+588
+316% +$905
LD
4092
DELISTED
iPath Bloomberg Lead Subindex Total Return ETN due June 24, 2038
LD
$1K ﹤0.01%
+20
New +$830
OIG
4093
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$1K ﹤0.01%
+3
New +$658
ATCO
4094
DELISTED
Atlas Corp.
ATCO
$1K ﹤0.01%
+40
New +$789
REED
4095
DELISTED
Reeds, Inc. Common Stock
REED
$1K ﹤0.01%
4
+1
+33% +$292
SMIT
4096
DELISTED
Schmitt Industries Inc
SMIT
$1K ﹤0.01%
204
-5
-2% -$14
CCXI
4097
DELISTED
ChemoCentryx, Inc.
CCXI
$1K ﹤0.01%
100
-781
-89% -$6.2K
HSTO
4098
DELISTED
Histogen Inc. Common Stock
HSTO
$1K ﹤0.01%
1
-3
-75% -$3.52K
LUB
4099
DELISTED
Luby's Inc.
LUB
$1K ﹤0.01%
273
-1,023
-79% -$5.36K
SFUN
4100
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$1K ﹤0.01%
2
-8
-80% -$3.19K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,185 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.